secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2025-08-04T23:59:59+00:00
Accession:  0001477932-25-005422
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx raises $1.21M in registered direct offering; insiders buy stock
--------------------------------------------------------------------------

- 156,250 shares sold to directors/officers at $0.64/share; 1,734,375 shares + warrants at $0.64/unit.
- Gross proceeds of $1.21M; potential additional $1.3M from warrants at $0.768/share.
- Warrants exercisable for 5 years from Aug 2025; insiders receive no warrants.
- No placement agent; offering expected to close Aug 5, 2025.
- Net proceeds for R&D, product development, clinical studies, working capital, and potential M&A.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793225005422/0001477932-25-005422-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793225005422/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-25-005422

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer